FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
The FDA is reviewing Moderna's mRNA-based flu vaccine. If approved, it would be the first flu shot using mRNA technology. A decision is expected soon and could impact the biotech sector.
6.8Significance
1 source9.0Source trust